Estradiol is used in two primary contexts: (1) Menopausal hormone replacement therapy for cisgender women at lower doses (0.5-2mg oral), and (2) Gender-affirming feminizing hormone therapy for transgender women at moderate-to-high doses (4-8mg+ oral, or 4-10mg weekly injectable monotherapy). For menopausal use, prescribe at the lowest effective dose for shortest duration necessary. When prescribed to individuals with an intact uterus, progestin co-administration reduces endometrial hyperplasia risk. For gender-affirming care, adequate testosterone suppression is the primary goal; many require 6-8mg oral or injectable monotherapy. Contraindicated in estrogen-dependent tumors, active thromboembolic disorders, undiagnosed vaginal bleeding, and pregnancy.
Estradiol molecular structure diagram from the DrugsPRO substance library.
Also known as: E2, Oestradiol, Β-estradiol, 17β-estradiol, Estrogen therapy, Estradiol-17β, Cis-Estradiol, Estradiol Cypionate
Check interactions before mixing substances, pay attention to dose spacing and hydration, and treat all dosage guidance as approximate rather than guaranteed safe.
Sources
Substance data is aggregated from the following public harm-reduction and reference sources.
This static page is intended as a readable non-JS and prerender-friendly library export.
Get the full DrugsPRO experience
Open the interactive DrugsPRO app for search, saved items, interactions, and deeper harm reduction tools.
Get the PRO test kit. The simple, quick and reliable drug checking test kit. Visit https://protestkit.eu
Estradiol - Guide des substances DrugsPRO
Estradiol: Estradiol is used in two primary contexts: (1) Menopausal hormone replacement therapy for cisgender women at lower doses (0.5-2mg oral), and (2) Gender-affirming feminizing hormone therapy for transgender women at moderate-to-high doses (4-8mg+ oral, or 4-10mg weekly injectable monotherap
